Related Experiment Video

Updated: Jun 26, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Targeting calcium/calmodulin-dependence kinase I and II as a potential anti-proliferation remedy for endometrial

Noriyuki Takai1, Tami Ueda, Kaei Nasu

  • 1Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, 1-1 Idaigaioka, Hasama-machi, Yufu-shi, Oita, Japan. takai@med.oita-u.ac.jp

Cancer Letters
|January 27, 2009
PubMed

Insights

Calcium/calmodulin-dependent kinase (CaMK) I and II are linked to endometrial cancer

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Endometrial cancer exhibits variable malignant potential.
  • Calcium/calmodulin-dependent kinases (CaMK) I and II are implicated in cellular processes.
  • CaMKs are potential targets for cancer therapy.

Purpose of the Study:

  • To investigate the role of CaMK I and II expression in endometrial cancer.
  • To evaluate CaMKs as therapeutic targets in endometrial cancer.
  • To assess the efficacy of the CaMK inhibitor KN-93.

Main Methods:

  • Analysis of CaMK I and II expression in endometrial cancer cell lines.
  • Correlation of CaMK expression with clinicopathological features (PCNA index, stage, grade, myometrial invasion).
  • Assessment of KN-93's effect on cell growth, cell cycle arrest, and apoptosis.

Main Results:

  • CaMK I and II expression positively correlated with endometrial cancer's malignant potential.
  • Expression levels were associated with PCNA index, clinical stage, grade, and invasion depth.
  • KN-93 demonstrated significant growth-inhibitory effects, inducing G0/G1 arrest and apoptosis.

Conclusions:

  • CaMK I and II expression is a marker for endometrial cancer malignancy.
  • CaMK I and II represent promising therapeutic targets for endometrial cancer.
  • KN-93 shows potential as a novel treatment for endometrial cancers.

More Related Videos

Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis07:46

Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis

Published on: October 13, 2023

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...